• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Anthem Biosciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 33976.0
  • ISIN : INE0CZ201020
757.35 -1 (-0.13%)
  • As on 27 Jul 2025 (EOD)

  • Today’s Low

    737.30

  • Today’s High

    762.70

  • Open

    753.00

  • Perv Close

    758.30

  • 52W Low

    701.90

  • 52W High

    770.00

Key Indicators

  • P/E(TTM)

    83.86

  • Mar.Cap (₹Cr.)

    42,533.54

  • Div & Yield %

    0.00

  • Book Value(₹)

    44.05

  • Debt-Equity Ratio

    -0.13

  • AGM Date

    25-Jul-2025

  • EPS

    9.02

  • P/E Ratio

    83.86

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    42,533.54

  • RONW (%)

    20.04

  • ROCE (%)

    23.98

Score Board

  • Equity (₹ in Cr.)

    112.32

  • BV (₹)

    44.00

  • Sales( ₹ in Cr.)

    1,840.65

  • NP (in Cr.)

    506.45

  • NP Var(%)

    35.0

  • Div%

    0.0

  • CPS (₹)

    10.40

  • EPS (₹)

    9.00

  • Traded Value (₹ in Lakhs)

    42,480.18

  • 52 Week High

    770.00

  • 52 Week Low

    701.90

  • Price BSE

    756.0

  • Price NSE

    757.00

  • Market Capital( in Cr.)

    42,480.18

  • P/C Ratio

    72.70

  • P/E Ratio

    83.80

  • Price Vs.BV

    9.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,840.65 1,417.54 1,056.92 1,231.26 1,103.24 632.72
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,840.65 1,417.54 1,056.92 1,231.26 1,103.24 632.72
Other Income 109.44 70.52 139.17 48.98 37.21 20.76
Stock Adjustments 86.70 41.23 9.01 1.37 -39.12 37.86
Total Income 2,036.79 1,529.29 1,205.10 1,281.61 1,101.33 691.34
EXPENDITURE :            
Raw Materials 828.08 640.77 348.29 410.30 407.88 284.29
Power and Fuel Cost 42.56 31.29 38.95 36.32 34.23 30.42
Employee Cost 251.76 182.65 153.24 137.51 142.19 120.15
Other Manufacturing Expenses 46.27 34.13 21.11 23.38 22.76 14.46
Selling and Administration Expenses 56.41 54.67 60.66 48.21 33.66 31.83
Miscellaneous Expenses 13.08 10.25 12.68 11.46 15.67 7.52
Employee Benefit Expenses 251.76 182.65 153.24 137.51 142.19 120.15
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,238.15 953.77 634.92 667.18 656.38 488.66
Operating Profit 798.65 575.52 570.19 614.44 444.95 202.68
Interest 9.29 9.26 8.71 10.09 16.97 20.43
Gross Profit 789.36 566.26 561.48 604.35 427.98 182.25
Depreciation 77.94 81.49 63.70 57.76 62.40 61.58
Profit Before Tax 711.42 484.77 497.78 546.59 365.58 120.67
Current Tax 182.03 126.41 120.05 142.39 96.70 33.25
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 23.21 -16.42 -7.94 -1.79 -2.43 -5.29
Reported Net Profit 506.19 374.78 385.67 405.99 271.31 92.70
Extraordinary Items -0.26 -0.21 40.84 -0.14 -0.14 0.06
Adjusted Net Profit 506.45 374.99 344.83 406.13 271.45 92.64
Adjustment below Net Profit -50.62 -71.60 -139.35 0.00 0.00 0.00
P & L Balance brought forward 1,524.15 1,220.97 974.65 568.66 336.62 279.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 9.64
P & L Balance carried down 1,979.72 1,524.15 1,220.97 974.65 607.93 362.71
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 9.05 6.70 6.76 462.60 319.76 110.63
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 44.24 34.58 30.53 1,544.46 826.76 503.43
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    74.69%

  • Public Share Holding

    25.31%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 408,054,643 72.66 408,054,643 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 11,409,736 2.03 11,409,736 2
Others 0 0.00 0 0
Sub Total 419,464,379 74.69 419,464,379 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 4,237,505 0.75 4,237,505 35
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,415,872 1.50 8,415,872 83
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,160,038 0.38 2,160,038 25
Mutual Funds / UTI 12,399,519 2.21 12,399,519 21
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,465,001 0.26 1,465,001 56
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 28,677,935 5.11 28,677,935 220
2] Non Institution
Bodies Corporate 22,407,534 3.99 22,407,534 201
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 44,440 0.01 44,440 812
Foreign Non Institution Other 15,396,327 2.74 15,396,327 1
Hindu Undivided Families 1,595,487 0.28 1,595,487 20,583
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 43,327,280 7.71 43,327,280 5
Individuals holding nominal share capital up to Rs. 1 lakh 30,696,305 5.47 30,696,305 804,012
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 364 0.00 364 1
Others 0 0.00 0 0
Sub Total 113,467,737 20.20 113,467,737 825,615
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 561,610,051 100.00 561,610,051 825,844

Company Background

Anthem Biosciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Anthem Biosciences Ltd
  • BSE Code : 33976.0
  • ISIN : INE0CZ201020

  • Incorporation Year

    2006

  • Registered Office

    49 F1 & F2 Canara Bank Road
    Bommasandra Industrial Area, Bangalore,
    Karnataka-560099

  • Telephone

    +91 080 6672 4000

  • FAX

  • Chairman

    Ajay Bhardwaj

  • Managing Director

  • Company Secretary

    Divya Prasad

  • Auditor

    K P Rao & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Anthem Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Anthem Bioscienc 756.40 1,950.09 1,840.65 83.95 30.46
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10